Mannose-binding Lectin (MBL)
Test Catalog Information
| Test Catalog Synonyms | |
| EPIC Synonyms | Mannan Binding Lectin |
| Cerner Primary Mnemonic | Mannan Binding Lectin |
| EPIC Display Name | Mannose-binding Lectin (MBL) |
| Allscripts (AEHR) Order Name | Mannan Binding Lectin (MBL) |
| Sunrise Clinical Manager (SCM) Order Name | Mannose Binding Lectin |
| EPIC Inpatient Orderable | Yes |
| EPIC Outpatient Orderable | Yes |
| Cerner Results |
MBL |
| Clinical Info |
The determination of MBL concentrations in serum may be useful for the elucidation of suspected immune defects and as a prognostic indicator alerting to the need for heightened therapeutic or prophylactic measures in immunosuppressed patients, including patients receiving cancer chemotherapy and patients with cystic fibrosis, SLE, or rheumatoid arthritis. |
| Specimen Type |
Blood |
| Container |
Gold Top Tube |
| Collection Instructions |
Container/Tube: Gold Top tube Specimen Volume: 0.5 ml Serum (0.2 mL min) Transport Temperature: Room Temperature |
| Transport Instructions |
Frozen |
| Specimen Stability |
14 Days Room Temperature 14 Days Refrigerated 14 Days Frozen |
| Methodology |
Enzyme-linked immunosorbent assay (ELISA) using microwells coated with the unique monoclonal antibody to capture MBL via an epitope near its carbohydrate-binding site. Bound MBL is detected with the same antibody that has been labeled with biotin. |
| Days Performed |
TAT: 6-8 Days |
| Performing Laboratory |
LabCorp |
| CPT |
83520 LOINC Code: 30152-3 |
| PDM |
1459854 |
Desired Epic Build Mannose-binding Lectin (MBL)
| Cerner Primary Mnemonic: | Mannan Binding Lectin | ||||||
| PDM | 1459854 | ||||||
| Informatics - Workgroup | Immunology | ||||||
| Synonyms * | Mannan Binding Lectin | ||||||
| Display Name * | Mannose-binding Lectin (MBL) | ||||||
| Order Entry Specimen Sources * | |||||||
| Order Entry Specimen Types |
Blood
| ||||||
| Specimen Navigator Specimen Types | |||||||
| Specimen Navigator Specimen Sources | |||||||
| Specimen Navigator Short Name | |||||||
| Ordering info (EPIC SmartText) | The determination of MBL concentrations in serum may be useful for the elucidation of suspected immune defects and as a prognostic indicator alerting to the need for heightened therapeutic or prophylactic measures in immunosuppressed patients, including patients receiving cancer chemotherapy and patients with cystic fibrosis, SLE, or rheumatoid arthritis. | ||||||
| IP Orderable | Yes | ||||||
| OP Orderable | Yes | ||||||
|
AOEs * | |||||||
| AP AOEs | |||||||
| Special History | No | ||||||
| Build Comments | |||||||
| Filter * | |||||||
| Procedure Category Change | |||||||
Cerner Results
| |||||||
Actual Epic build
| Procedure Id | 111696 | ||||||||||||||||||||||||
| Pdm | 1459854 | ||||||||||||||||||||||||
| Order Display Name | Mannose-binding Lectin (MBL) | ||||||||||||||||||||||||
| Procedure Name | MANNAN BINDING LECTIN | ||||||||||||||||||||||||
| Procedure Master Number | LAB10596 | ||||||||||||||||||||||||
| Short Procedure Name | MANNAN BINDING LECTIN | ||||||||||||||||||||||||
| Category Code | 1.0 | ||||||||||||||||||||||||
| Category Code Record Name | LAB BLOOD ORDERABLES | ||||||||||||||||||||||||
| Synonyms | MANNAN BINDING LECTIN | ||||||||||||||||||||||||
| Clinically Active | Yes | ||||||||||||||||||||||||
| Orderable | Yes | ||||||||||||||||||||||||
| Performable | Yes | ||||||||||||||||||||||||
| Filter Genomics | |||||||||||||||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/111696 | ||||||||||||||||||||||||
| Ordering Instructions | |||||||||||||||||||||||||
| Default Specimen Type | Blood | ||||||||||||||||||||||||
| Specimen Type Pick List | Blood | ||||||||||||||||||||||||
| Specimen Type List | |||||||||||||||||||||||||
| Op Specimen Type List | |||||||||||||||||||||||||
| Specimen Source Pick List | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||||||||||||||
| Specimen Source Default - Male | Blood, Venous | ||||||||||||||||||||||||
| Specimen Source Default - Female | Blood, Venous | ||||||||||||||||||||||||
| Specimen Source List | |||||||||||||||||||||||||
| Op Specimen Source List | |||||||||||||||||||||||||
| Ip Lab Test Components For Report | |||||||||||||||||||||||||
| Op Lab Test Components For Report | |||||||||||||||||||||||||
| Order Questions | ["3045300170", "3045300171", "3045300173"] | ||||||||||||||||||||||||
| Order Questions Record Name | NH IP HOME COLLECT DATE NH IP HOME COLLECT DAYS NH IP HOME COLLECT MEDICALLY NECESSARY | ||||||||||||||||||||||||
| Inpatient Order Questions | [] | ||||||||||||||||||||||||
| Inpatient Order Questions Record Name | |||||||||||||||||||||||||
| Order Specific Question Override | Yes | ||||||||||||||||||||||||
| Inpatient Question Override | |||||||||||||||||||||||||
| Location Restrict List Ip | |||||||||||||||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||||||||||||||
| Location Restrict List Include Ip | |||||||||||||||||||||||||
| Location Restrict List Op | |||||||||||||||||||||||||
| Location Restrict List Op Record Name | |||||||||||||||||||||||||
| Location Restrict List Includes Op | |||||||||||||||||||||||||
| Edp Amb Order Specific Questions Record Name | |||||||||||||||||||||||||
| Edp Ip Order Specific Questions Record Name | |||||||||||||||||||||||||
| Edp Ip Specimen Source | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary | ||||||||||||||||||||||||
| Edp Op Specimen Source | |||||||||||||||||||||||||
| Edp Ip Specimen Type | Blood | ||||||||||||||||||||||||
| Edp Op Specimen Type | |||||||||||||||||||||||||
| Derived Edp Ip Buttons S | Blood, Capillary Blood, Venous Blood, Central Line Blood, Arterial | ||||||||||||||||||||||||
| Derived Edp Ip Buttons T | Blood | ||||||||||||||||||||||||
| Derived Edp Op Buttons S | |||||||||||||||||||||||||
| Derived Edp Op Buttons T | |||||||||||||||||||||||||
| Ip Orderable | 1 | ||||||||||||||||||||||||
| Op Orderable | 1 | ||||||||||||||||||||||||
EPIC OP AOEs
| |||||||||||||||||||||||||
| EPIC IP AOEs | |||||||||||||||||||||||||
EPIC Components (results)
| |||||||||||||||||||||||||